GRI Bio, Inc. (NASDAQ:GRI) IPO
IPO
Went public as Vallon Pharmaceuticals, Inc. Priced at US$8.00 a share on Feb 9, 2021.
- Price
- US$8.00 a share
- Shares offered
- 2,250,000 shares of common stock
- Offering size
- US$18 million
- Underwriters' option
- Up to 337,500 more shares
- Listing
- VLON on the Nasdaq Capital Market
- Underwriter
- ThinkEquity
- Shares delivered
- On or about Feb 12, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Sep 11, 2020 |
| Filed publicly | Oct 23, 2020 |
| Amended 3 times | Newest Jan 28, 2021 |
| Shares registered with an exchange | Feb 8, 2021 |
| Declared effective by the SEC | Feb 9, 2021 |
| Final prospectus, with the price | Feb 11, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Feb 11, 2021 |
| EFFECT · Notice that a registration is effective | Feb 9, 2021 |
| S-1MEF · Registration of more shares for the same offering | Feb 9, 2021 |
| CERT · Exchange's certificate of listing | Feb 9, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Feb 8, 2021 |
| CORRESP · Letter to the SEC | Feb 3, 2021 |
| CORRESP · Letter to the SEC | Feb 3, 2021 |
| CORRESP · Letter to the SEC | Feb 2, 2021 |
| CORRESP · Letter to the SEC | Feb 1, 2021 |
| CORRESP · Letter to the SEC | Feb 1, 2021 |
| CORRESP · Letter to the SEC | Jan 28, 2021 |
| S-1/A · Registration statement, amended | Jan 28, 2021 |
| UPLOAD · Letter from the SEC | Jan 22, 2021 |
| FWP · Free writing prospectus | Jan 21, 2021 |
| S-1/A · Registration statement, amended | Jan 14, 2021 |
| CORRESP · Letter to the SEC | Nov 16, 2020 |
| S-1/A · Registration statement, amended | Nov 16, 2020 |
| UPLOAD · Letter from the SEC | Nov 6, 2020 |
| CORRESP · Letter to the SEC | Oct 23, 2020 |
| S-1 · Registration statement | Oct 23, 2020 |
| UPLOAD · Letter from the SEC | Oct 9, 2020 |
| DRS · Draft registration statement | Sep 11, 2020 |
From the cover of the final prospectus (424B4) filed Feb 11, 2021